Metastatic Colorectal Cancers Completed Phase 1 Trials for Sorafenib (DB00398)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00780169Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal CancerTreatment